Genomic News and Research

RSS

Researchers reveal novel computational tool used to analyze genetic variation

The field of genetic sequencing has undergone a dramatic revolution over the past 20 years. In 2001 the first copy of the three billion base pairs that assemble the human genome was published.

8 Feb 2019

New prostate cancer prediction tool has unmatched accuracy

A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.

7 Feb 2019

Insufficient sleep mirrored by DNA from blood leukocytes

An insufficient amount of sleep and qualitatively poor sleep are common among the general population. Prior studies have indicated that prolonged insufficient sleep and poor sleep quality are associated with a heightened risk of cardiovascular diseases, dementia and psychiatric disorders, particularly depression, yet the molecular mechanisms underlying this connection are not well known.

7 Feb 2019

Cannabinoid receptor type 1 appears to be potential target to treat Down syndrome

A study by the Neuropharmacology Laboratory-NeuroPhar of the Department of Experimental and Health Sciences at UPF reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome.

7 Feb 2019

Simulation model to find the most optimal cancer treatment

In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.

6 Feb 2019

ALS and Tow Foundation announce their continuing support to New York Genome Center

The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.

6 Feb 2019

New technology can detect any virus that poses a threat to humans

Researchers have developed a computational method that designs molecular “baits” for any strains of virus known to infect humans, including Zika virus.

5 Feb 2019

New disease surveillance tool enables early detection of viral outbreaks

During the Zika virus outbreak of 2015-16, public health officials scrambled to contain the epidemic and curb the pathogen's devastating effects on pregnant women. At the same time, scientists around the globe tried to understand the genetics of this mysterious virus.

5 Feb 2019

Mapping mutations in esophageal cancer could improve treatment options

Mutations that cause oesophageal adenocarcinoma have been mapped in unprecedented detail - unveiling that more than half could be targeted by drugs currently in trials for other cancer types.

4 Feb 2019

Study sheds new light on genetics of diabetes in Japanese population

The genetic and genomic revolutions have led to an abundance of data about the genetic factors that confer a predisposition to type 2 diabetes, alongside environmental and lifestyle-related causes.

4 Feb 2019

Researchers use integrated data analysis to classify liver cancer

Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally.

3 Feb 2019

Opioid overdose epidemic likely to increase in the U.S in coming years

A study from investigators at the Massachusetts General Hospital Institute for Technology Assessment projects that the opioid overdose epidemic in the U.S. is likely to increase in coming years, and that measures based on restricting access to prescription opioids will have a minimal impact in reducing overdose deaths.

3 Feb 2019

Genetic testing improves diagnoses of abnormalities in developing babies

Genetic testing improves the diagnoses of abnormalities in developing babies that are picked up during ultrasound scans, scientists report today (31 January) in The Lancet.

1 Feb 2019

Discovery of proteins that control mucin secretion reveals clues to treating colon, airway diseases

Cells produce mucins at a constant rate, and when exposed to an allergen or pathogen, they produce more mucin in a rapid burst. Both the constant and rapid mucin secretion is controlled by calcium.

1 Feb 2019

Newly discovered molecules show potential to treat obesity and fatty liver disease

Amiram Goldblum and his team at the Hebrew University of Jerusalem's Institute for Drug Research have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.

31 Jan 2019

Study reveals how glioblastomas resist the effects of antiangiogenic drugs

A study led by investigators from Massachusetts General Hospital (MGH) and the University of Cyprus reveals details of a way the dangerous brain tumors called glioblastomas resist the effects of antiangiogenic drugs designed to cut off their blood supply.

31 Jan 2019

Metagenomic analysis helps understand role of bacterial species in Crohn's disease

Research on gut metagenome of patients with Crohn's disease elucidates how it influences the taxonomic and functional composition of intestinal microbiota.

31 Jan 2019

Researchers call for industry standards to help improve high-throughput genomic sequencing

Researchers from the George Washington University, the U.S. Food and Drug Administration, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.

31 Jan 2019

New type of genomic screening developed to produce novel drugs

Prof. Dr Mikhail Yakimov, a researcher from the Immanuel Kant Baltic Federal University, together with his colleagues from the Heinrich Heine University Düsseldorf, Norwegian Research Centre NORCE AS, School of Natural Sciences of CEU San Pablo University and Institute of Catalysis and Petrochemistry in Madrid (Spain), has conducted a study of universal transaminase enzymes.

31 Jan 2019

FSU study breaks new ground in the battle against malignant pediatric brain cancers

Scientists are making important progress in the battle against a class of devilishly complex human pediatric brain cancers thanks to a new study from a team of Florida State University students and faculty.

30 Jan 2019